Access to Patients (A2P) is a leading patient recruitment marketing company providing patient recruitment services for top pharmaceutical companies across the globe, as well as individual study sites. A2P approaches clinical trial recruitment from an innovative and cutting-edge perspective – a dynamic integration of traditional media methods and ePatient engagement. From years of experience we know what traditional media method works within each specific patient population. In recruiting for clinical trials, we match successful traditional media methods and integrate our innovative digital approach to create a synergy of recruitment promotion.

What is ePatient engagement?

ePatient engagement is clinical trial recruitment marketing done in the online landscape. Access to Patients uses sophisticated internet search tools to find out what people are talking about and the terms and phrases they are using to talk about it. These buzz metrics allow us to have in-depth knowledge of how patients communicate. With this information we can hyper-target only the people who are actively searching for information about their specific disease or medical condition, treatment options, and clinical trials. Using a combination of strategic banner and text ads that combine the recruitment message with the terms and phrases being used by patient populations, we effectively and efficiently reach the patients that are looking to enroll.

Social Engagement

Access to Patients not only promotes clinical trials via online advertising, we get social. Using social media outlets to approach patients from a more personal approach, A2P discusses clinical trials in online forums, blogs, discussion boards, Facebook groups and pages, as well as countless other social outlets. Instead of making the patient come find us, we take the recruitment message to them in their own social worlds.

Integrating a highly strategical offline approach with a hyper-targeted digital approach ensures A2P captures the entire audience with a synergy of recruitment messaging.